Tech Company Financing Transactions
MycoWorks Funding Round
On 1/20/2022, MycoWorks received $125 million in Series C funding from Prime Movers Lab, Data Collective and Novo Ventures.
Transaction Overview
Company Name
Announced On
1/20/2022
Transaction Type
Venture Equity
Amount
$125,000,000
Round
Series C
Investors
Proceeds Purpose
The Series C funding round will be used to launch the first full-scale Fine Mycelium production plant to meet the growing demand for the company's materials, including MycoWorks' flagship product, Reishi.
Company Information
Company Status
Private & Independent
Industry
Advanced Materials
Mailing Address
669 Grand View Ave.
San Francisco, CA 94114
USA
San Francisco, CA 94114
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
MycoWorks is a biotechnology company that makes fine leathers from mycelium (mushroom) for applications in luxury fashion, footwear, and beyond. We are currently shipping product, and we are backed by some of the leading venture capital firms in Silicon Valley. Our mission is to impact the world with new materials that have superior performance to animal leathers and plastic.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Matthew Scullin
Browse more venture capital transactions:
Prev: 1/20/2022: Jaanuu venture capital transaction
Next: 1/20/2022: Inxeption venture capital transaction
Share this article
News on VC Transactions
We do our best to record funding rounds that are announced publicly. VC investment data records reported here are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs